RWAY stock news
This page provides real-time market news, earnings updates, and company announcements related to Runway Growth Finance Corp. (RWAY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 11:28 EST
Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-31 11:33:51
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
Finviz2026-03-31 11:33:50
OS Therapies Completes Submission of Biomarker & Clinical Data for U.S. FDA Pre-BLA Meeting, Reports Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-31 11:42:53
McCormick to Combine with Unilever's Foods Business, Creating a Preeminent Global Flavor-Focused Company
Finviz2026-03-31 12:00:09
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
Finviz2026-03-31 12:03:48
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Finviz2026-03-31 12:03:48
TRNR Reports Record Full-Year 2025 Results, Driven by 114% Revenue Growth; Confirms 2026 Guidance of $30M+ in Pro Forma Revenue & $0.5M Stock Repurchase Program
Finviz2026-03-31 13:52:04
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Finviz2026-03-31 20:03:46
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
Finviz2026-03-31 20:09:07
Aqua Metals Reports 2025 Milestone Advancements, Strategic Progress, and Continued Commercialization Momentum
Finviz2026-03-31 20:09:08
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
Finviz2026-04-01 11:03:11
ADC Therapeutics Announces New Employee Inducement Grant
Finviz2026-04-01 20:06:55
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-04-01 21:03:44
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
Finviz2026-04-02 21:18:49
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
Finviz2026-04-06 11:03:55
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028
Finviz2026-04-07 12:33:47
Runway Growth Finance Corp. Closes Acquisition of SWK Holdings Corporation and Provides First Quarter 2026 Business and Portfolio Update
Finviz2026-04-07 12:33:48
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
Finviz2026-04-08 11:03:45
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
Finviz2026-04-08 15:39:53
Cyngn Accelerates Autonomous Vehicle Adoption in 2026
Finviz2026-04-09 11:18:08
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Finviz2026-04-10 12:33:49
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
Finviz2026-04-13 11:33:07
AMD hits all-time high, Intel surges — Proxy AI drives a turning point in CPU demand, kicks off server price hike cycle, and resonates with Intel's foundry story
404k2026-04-17 03:18:22
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
Finviz2026-03-31 12:03:48
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Finviz2026-03-31 12:03:48
TRNR Reports Record Full-Year 2025 Results, Driven by 114% Revenue Growth; Confirms 2026 Guidance of $30M+ in Pro Forma Revenue & $0.5M Stock Repurchase Program
Finviz2026-03-31 13:52:04
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Finviz2026-03-31 20:03:46
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
Finviz2026-03-31 20:09:07
Aqua Metals Reports 2025 Milestone Advancements, Strategic Progress, and Continued Commercialization Momentum
Finviz2026-03-31 20:09:08
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
Finviz2026-04-01 11:03:11
ADC Therapeutics Announces New Employee Inducement Grant
Finviz2026-04-01 20:06:55
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-04-01 21:03:44
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
Finviz2026-04-02 21:18:49
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
Finviz2026-04-06 11:03:55
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028
Finviz2026-04-07 12:33:47
Runway Growth Finance Corp. Closes Acquisition of SWK Holdings Corporation and Provides First Quarter 2026 Business and Portfolio Update
Finviz2026-04-07 12:33:48
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
Finviz2026-04-08 11:03:45
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
Finviz2026-04-08 15:39:53
Cyngn Accelerates Autonomous Vehicle Adoption in 2026
Finviz2026-04-09 11:18:08
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Finviz2026-04-10 12:33:49
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
Finviz2026-04-13 11:33:07
AMD hits all-time high, Intel surges — Proxy AI drives a turning point in CPU demand, kicks off server price hike cycle, and resonates with Intel's foundry story
404k2026-04-17 03:18:22
RWAY stock chart
RWAY stock detailsRWAY stock price change
On the last trading day, RWAY stock closed at 6.80 USD, with a price change of 4.78% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more